回忆录
发表于 2025-3-21 19:10:28
书目名称Breast Cancer Survivorship影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0190575<br><br> <br><br>书目名称Breast Cancer Survivorship影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0190575<br><br> <br><br>书目名称Breast Cancer Survivorship网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0190575<br><br> <br><br>书目名称Breast Cancer Survivorship网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0190575<br><br> <br><br>书目名称Breast Cancer Survivorship被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0190575<br><br> <br><br>书目名称Breast Cancer Survivorship被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0190575<br><br> <br><br>书目名称Breast Cancer Survivorship年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0190575<br><br> <br><br>书目名称Breast Cancer Survivorship年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0190575<br><br> <br><br>书目名称Breast Cancer Survivorship读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0190575<br><br> <br><br>书目名称Breast Cancer Survivorship读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0190575<br><br> <br><br>
ICLE
发表于 2025-3-21 23:15:00
Introduction,east cancer survivors”: women living with a past history of breast cancer. This number is projected to reach nearly 2 million by 2040. In current breast surgical and oncological practice many of these women will be discharged from routine follow-up. However, these patients will not only continue to
表皮
发表于 2025-3-22 01:33:13
Endocrine Therapyal ongoing trials. In pre-menopausal women, where AIs are contraindicated, tamoxifen has been the standard of care. However recently, the role of ovarian function suppression/ablation in combination with tamoxifen or exemestane has been shown to be superior to tamoxifen alone in selected pre-menopau
intelligible
发表于 2025-3-22 05:41:36
http://reply.papertrans.cn/20/1906/190575/190575_4.png
CUB
发表于 2025-3-22 12:05:08
http://reply.papertrans.cn/20/1906/190575/190575_5.png
睨视
发表于 2025-3-22 13:33:47
http://reply.papertrans.cn/20/1906/190575/190575_6.png
上下连贯
发表于 2025-3-22 19:52:13
Absolute Continuity of Probability Lawsal ongoing trials. In pre-menopausal women, where AIs are contraindicated, tamoxifen has been the standard of care. However recently, the role of ovarian function suppression/ablation in combination with tamoxifen or exemestane has been shown to be superior to tamoxifen alone in selected pre-menopau
旁观者
发表于 2025-3-22 21:38:04
http://reply.papertrans.cn/20/1906/190575/190575_8.png
打包
发表于 2025-3-23 04:01:43
The Donsker Delta Function and Applications In addition, exciting new data suggest that bisphosphonates may also modify the metastatic disease process with recently published meta-analyses data demonstrating a reduction in bone recurrence and an improvement in breast cancer survival in post-menopausal women.
hedonic
发表于 2025-3-23 08:16:53
http://reply.papertrans.cn/20/1906/190575/190575_10.png